Published date: 19 May 2025

Open future opportunity - This means that the buyer is not yet ready to invite bid applications but early notification has been provided and some dialogue may be possible.


Approach to market date: 16 June 2025

Contract summary

Industry

  • Research and experimental development services - 73100000

  • Research and development consultancy services - 73200000

  • Design and execution of research and development - 73300000

Location of contract

United Kingdom, Europe

Value of contract

£1,338,000 to £1,673,000

Procurement reference

xxxx

Published date

19 May 2025

Approach to market date

16 June 2025

Contract start date

29 August 2025

Contract end date

31 December 2027

Procedure type

Other: This is not a procurement of a Public Contract

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

Develop, test and deploy frameworks that will enable FSHD patients and FSHD patient advocacy organisations in The Netherlands, France, Germany, Italy, Belgium, Spain, and the United Kingdom to pragmatically and effectively lead, scale and harmonise cross-sector collaboration through utilising the Interactium. Ensure FSHD patients are supported through decisions concerning participation in clinical trials and ultimately help move critical research forward through a navigator program.
Generate an Interactium-compatible HTA assessment model for FSHD with a set of SOPs to enable other groups to recreate this work.

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2026/2027 £500,000

Additional text

Treat-NMD will be inviting tenders in the near future for this piece of work.

How to apply

Follow the instructions given in the description or the more information section.

About the buyer

Contact name

Harry Fisher

Address

Broadway
SALFORD
M5 3EJ
England

Email

harry.fisher2@nhs.net